Precise prediction of size of a foldable capsular vitreous body via computerized three-dimensional ocular reconstruction in severe retinal detachment.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
20 Sep 2024
Historique:
received: 05 05 2023
accepted: 19 08 2024
medline: 21 9 2024
pubmed: 21 9 2024
entrez: 20 9 2024
Statut: epublish

Résumé

This study aimed to precisely predict the size and silicone oil injection of a foldable capsular vitreous body (FCVB) via computerized three-dimensional (3D) ocular reconstruction in the treatment of severe retinal detachment in China. The 3D software Unigraphics NX was applied to determine the volume of the inner cavity with 16-30 mm axial length, assigning the anterior and posterior chambers, the FCVB sizes, and the silicone oil injection volume, and modeling the data between the axial length and the FCVB size. In clinical practice, IOL Master was applied to accurately measure the axial length of the contralateral healthy eye to anchor the anterior-posterior and horizontal diameters of the operated eye in horizontal position CT, and compared with the model to recommend the FCVB size and silicone oil amount, and the clinical effect was validated in cases across five hospitals in China. For the axial length of 16-30 mm, the volume of the inner cavity is 1.2 ml-8.4 ml. FCVB size and silicone oil volume were recommended based on this volume of the inner cavity. Of 253 cases, we noted 11 cases implanted with AV-10P and 1.05 ± 0.21 ml of silicone oil, 41 with AV-12P and 1.58 ± 0.18 ml of silicone oil, 163 with AV-13.5P and 2.48 ± 0.29 ml of silicone oil, 31 with AV-15P and 3.57 ± 0.39 ml of silicone oil, and 7 with AV-17P and 5.71 ± 0.81 ml of silicone oil. There was no significant difference in postoperative visual acuity scores compared with preoperative (P = 0.097), postoperative IOP(10.29 ± 0.57mmHg)was slightly higher than preoperative IOP (9.76 ± 0.48 mmHg), but there was still no statistically significant difference between the two comparisons (P = 0.405). Three-dimensional reconstruction prediction is a good solution for eyeballs with obvious individualized changes in severe retinal detachment, and this method helps doctors standardize FCVB size selection and the silicone oil amount for patients.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to precisely predict the size and silicone oil injection of a foldable capsular vitreous body (FCVB) via computerized three-dimensional (3D) ocular reconstruction in the treatment of severe retinal detachment in China.
METHODS METHODS
The 3D software Unigraphics NX was applied to determine the volume of the inner cavity with 16-30 mm axial length, assigning the anterior and posterior chambers, the FCVB sizes, and the silicone oil injection volume, and modeling the data between the axial length and the FCVB size. In clinical practice, IOL Master was applied to accurately measure the axial length of the contralateral healthy eye to anchor the anterior-posterior and horizontal diameters of the operated eye in horizontal position CT, and compared with the model to recommend the FCVB size and silicone oil amount, and the clinical effect was validated in cases across five hospitals in China.
RESULTS RESULTS
For the axial length of 16-30 mm, the volume of the inner cavity is 1.2 ml-8.4 ml. FCVB size and silicone oil volume were recommended based on this volume of the inner cavity. Of 253 cases, we noted 11 cases implanted with AV-10P and 1.05 ± 0.21 ml of silicone oil, 41 with AV-12P and 1.58 ± 0.18 ml of silicone oil, 163 with AV-13.5P and 2.48 ± 0.29 ml of silicone oil, 31 with AV-15P and 3.57 ± 0.39 ml of silicone oil, and 7 with AV-17P and 5.71 ± 0.81 ml of silicone oil. There was no significant difference in postoperative visual acuity scores compared with preoperative (P = 0.097), postoperative IOP(10.29 ± 0.57mmHg)was slightly higher than preoperative IOP (9.76 ± 0.48 mmHg), but there was still no statistically significant difference between the two comparisons (P = 0.405).
CONCLUSION CONCLUSIONS
Three-dimensional reconstruction prediction is a good solution for eyeballs with obvious individualized changes in severe retinal detachment, and this method helps doctors standardize FCVB size selection and the silicone oil amount for patients.

Identifiants

pubmed: 39304858
doi: 10.1186/s12886-024-03646-9
pii: 10.1186/s12886-024-03646-9
doi:

Substances chimiques

Silicone Oils 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

412

Informations de copyright

© 2024. The Author(s).

Références

Cibis PA, Becker B, Okun E, Canaan S. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol. 1962;68:590–9.
doi: 10.1001/archopht.1962.00960030594005 pubmed: 14021325
Hotta K, Sugitani A. Refractive changes in silicone oil-filled pseudophakic eyes. Retina. 2005;25(2):167–70.
doi: 10.1097/00006982-200502000-00009 pubmed: 15689807
Leaver PK, Grey RH, Garner A. Silicone oil injection in the treatment of massive preretinal retraction. II. Late complications in 93 eyes. Br J Ophthalmol. 1979;63(5):361–7.
doi: 10.1136/bjo.63.5.361 pubmed: 465413 pmcid: 1043489
Yeo JH, Glaser BM, Michels RG. Silicone oil in the treatment of complicated retinal detachments. Ophthalmology. 1987;94(9):1109–13.
doi: 10.1016/S0161-6420(87)33328-7 pubmed: 2446231
Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP. New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol. 2001;239(9):635–42.
doi: 10.1007/s004170100330 pubmed: 11688661
Ichhpujani P, Jindal A, Jay Katz L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol. 2009;247(12):1585–93.
doi: 10.1007/s00417-009-1155-x pubmed: 19685070
Yadav I, Purohit SD, Singh H, Bhushan S, Yadav MK, Velpandian T, Chawla R, Hazra S, Mishra NC. Vitreous substitutes: an overview of the properties, importance, and development. J Biomed Mater Res B Appl Biomater. 2021;109(8):1156–76.
doi: 10.1002/jbm.b.34778 pubmed: 33319466
Mondelo-García C, Bandín-Vilar E, García-Quintanilla L, Castro-Balado A, Del Amo EM, Gil-Martínez M, Blanco-Teijeiro MJ, González-Barcia M, Zarra-Ferro I, Fernández-Ferreiro A, Otero-Espinar FJ. Current situation and challenges in vitreous substitutes. Macromol Biosci. 2021;21(8):e2100066.
doi: 10.1002/mabi.202100066 pubmed: 33987966
Biswas J, Verma A, Davda MD, et al. Intraocular tissue migration of silicone oil after silicone oil tamponade: a histopathological study of enucleated silicone oil-filled eyes. Indian J Ophthalmol. 2008;56(5):425–8.
doi: 10.4103/0301-4738.42425 pubmed: 18711277 pmcid: 2636147
Hammer ME, Grizzard WS. Endoscopy for evaluation and treatment of the ciliary body in hypotony. Retina. 2003;23(1):30–6.
doi: 10.1097/00006982-200302000-00005 pubmed: 12652228
Mancino R, Aiello F, Ciuffoletti E, Di Carlo E, Cerulli A, Nucci C. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle. BMC Ophthalmol. 2015;15:173.
doi: 10.1186/s12886-015-0167-z pubmed: 26645589 pmcid: 4673732
Gao Q, Mou S, Ge J, To CH, Hui Y, Liu A, Wang Z, Long C, Tan J. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve. Eye (Lond). 2008;22(3):461–8.
doi: 10.1038/sj.eye.6702875 pubmed: 17525767
Liu Y, Jiang Z, Gao Q, Ge J, Chen J, Cao X, Shen Q, Ma P. Technical standards of a foldable capsular vitreous body in terms of mechanical, optical, and biocompatible properties. Artif Organs. 2010;34(10):836–45.
doi: 10.1111/j.1525-1594.2010.01006.x pubmed: 20618225
Gao Q, Chen X, Ge J, Liu Y, Jiang Z, Lin Z, Liu Y. Refractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyes. Invest Ophthalmol Vis Sci. 2009;50(7):3529–34.
doi: 10.1167/iovs.08-2802 pubmed: 19264881
Lin X, Ge J, Gao Q, Wang Z, Long C, He L, Liu Y, Jiang Z. Evaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment. Invest Ophthalmol Vis Sci. 2011;52(1):374–81.
doi: 10.1167/iovs.10-5869 pubmed: 20811065
Lin X, Sun X, Wang Z, Jiang Z, Liu Y, Wang P, Gao Q. Three-year efficacy and safety of a silicone oil-filled foldable-capsular-vitreous-body in three cases of severe retinal detachment. Transl Vis Sci Technol. 2016;5(1): 2.
doi: 10.1167/tvst.5.1.2 pubmed: 26855843 pmcid: 4736667
Wang P, Gao Q, Jiang Z, Lin J, Liu Y, Chen J, Zhou L, Li H, Yang Q, Wang T. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes. Clin Exp Ophthalmol. 2012;40(1):e67–75.
doi: 10.1111/j.1442-9071.2011.02664.x pubmed: 21883770
Xu X, Ge H, Li J, Shang W, Ji Y, Yang W, Li K. Outcomes of a foldable capsular vitreous body implantation: a retrospective study. Dis Markers. 2021;2021:6575195.
doi: 10.1155/2021/6575195 pubmed: 34987675 pmcid: 8720596
Zhang X, Tian X, Zhang B, Guo L, Li X, Jia Y. Study on the effectiveness and safety of foldable capsular vitreous body implantation. BMC Ophthalmol. 2019;19(1):260.
doi: 10.1186/s12886-019-1268-x pubmed: 31852464 pmcid: 6921415
Deng J, Song HP, Zhou RL, Chen T, Wang JZ, Zhu ZLD. Evaluation of the long-term effect of foldable capsular vitreous bodies in severe ocular rupture. Int J Ophthalmol. 2021;14(12):1935–40.
doi: 10.18240/ijo.2021.12.19 pubmed: 34926211 pmcid: 8640779
Chen S, Tian M, Zhang L, Hu C, Liu K, Qin B, Liu S. Reattachment after foldable capsular vitreous body implantation in severe retinal detachment eyes. Transl Vis Sci Technol. 2021;10(11): 8.
doi: 10.1167/tvst.10.11.8 pubmed: 34491287 pmcid: 8431979
Zhang Z, Liu S, Xie F, Jiang B, Sun M, Sun D. Comparison of viscoelastic substance injection versus air filling in the anterior chamber during foldable capsular vitreous body (FCVB) implant surgery: a prospective randomized controlled trial. Adv Ther. 2021;38(9):4859–71.
doi: 10.1007/s12325-021-01840-5 pubmed: 34351566 pmcid: 8408088
Li M, Tang Y, Li S, Zhang Z, Guan L, Li J, Xu J, Ji S. Foldable capsular vitreous body implantation for complicated retinal detachment caused by severe ocular trauma. Retina. 2022;42(8):1512–19.
Zhang C, Xiao R, Wang A, Zhao Z. Silicone oil-filled foldable capsular vitreous body versus silicone oil endotamponade for treatment of no light perception after severe ocular trauma. Retina. 2022;42(3):553–60.
Abu Serhan HA, Irshaidat S, Abu Serhan L, Elnahry AG. Foldable capsular vitreous body indications, complications, and outcomes: a systematic review. Graefes Arch Clin Exp Ophthalmol. 2023;2;36795160.
Schreurs R, Klop C, Maal T. Advanced diagnostics and three-dimensional virtual surgical planning in orbital reconstruction. Atlas Oral Maxillofac Surg Clin North Am. 2021;29(1):79.
Xue R, Lai Q, Sun S, Lai L, Tang X, Ci J, Zhang Z, Wang Y. Application of three-dimensional printing technology for improved orbital-maxillary-zygomatic reconstruction. J Craniofac Surg. 2019;30(2):e127–31.
Kunavisarut P, Poopattanakul P, Intarated C, Pathanapitoon K. Accuracy and reliability of IOL master and A-scan immersion biometry in silicone oil-filled eyes. Eye (Lond). 2012;26(10):1344–8.
Friberg TR, Guibord NM. Corneal endothelial cell loss after multiple vitreoretinal procedures and the use of silicone oil. Ophthalmic Surg Lasers. 1999;30(7):528–34. 
Miller JB, Papakostas TD, Vavvas DG. Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol. 2014;29(5-6):312–18.

Auteurs

Chongde Long (C)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.

Qianying Gao (Q)

Vesber Vitreous Institute, Guangzhou, 510060, China.

Shenwen Liu (S)

Shenzhen Eye Hospital, Shenzhen, China.

Yan Chen (Y)

Xiamen Eye Center of Xiamen University, Xiamen, China.

Huping Song (H)

Xi'an People's Hospital (Xi'an Fourth Hospital), Xian, China.

Jinguo Yu (J)

Tianjin Medical University General Hospital, Tianjin, China.

Bingsheng Lou (B)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.

Zhaohui Yuan (Z)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.

Yongxin Zheng (Y)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.

Liuxueying Zhong (L)

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Sun Yat-sen University, Guangzhou, 510060, China.

Siqi Qiao (S)

Vesber Vitreous Institute, Guangzhou, 510060, China.

Xiangda Meng (X)

Tianjin Medical University General Hospital, Tianjin, China.

Yuanyuan Liu (Y)

Tianjin Medical University General Hospital, Tianjin, China.

Yingyu Wang (Y)

Vesber Vitreous Institute, Guangzhou, 510060, China.

Yuanyuan Liu (Y)

Vesber Vitreous Institute, Guangzhou, 510060, China.

Xiaofeng Lin (X)

Aier Ophthalmology Institute, Aier Mansion, No.188 South Furong Road, Changsha City, Hunan province, China. linxiaof@mail.sysu.edu.cn.

Hua Yan (H)

Tianjin Medical University General Hospital, Tianjin, China. zyyyanhua@tmu.edu.cn.
Laboratory of Molecular Ophthalmology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China. zyyyanhua@tmu.edu.cn.
Medical School of Nankai University, Tianjin, China. zyyyanhua@tmu.edu.cn.
Department of Ophthalmology, Tianjin Medical University General Hospital Medical School of Nankai University, Tianjin, 300052, China. zyyyanhua@tmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH